A phase 1 glucose clamp trial investigating the bioequivalence of CVC-001 cartridge and vial formulations vs U.S.-Licensed Lantus® in healthy male volunteers

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516472-15-00

Acronym

CVC-22-001

Enrollment

Registered

2025-12-12

Start date

2026-01-06

Completion date

Unknown

Last updated

2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes mellitus (healthy participants)

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026